27 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:57 PM
Wockhardt Ltd.

BSE

  • 720.00 -6.70 (-0.92%)
  • Vol: 173544
  • BSE Code: 532300
  • PREV. CLOSE
    726.70
  • OPEN PRICE
    727.00
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • 719.25 0.00 (0%)
  • Vol: 511652
  • NSE Code: WOCKPHARMA
  • PREV. CLOSE
    719.25
  • OPEN PRICE
    729.00
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    719.25(425)

Wockhardt Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
24-Apr-201704-May-2017We wish to inform that meeting of the Board of Directors of Company will be held on 4th May, 2017, inter-alia, to consider and: (i)approve the Audited Financial Results (Standalone & Consolidated) for quarter & year ended 31st March, 2017; (ii)recommend dividend on Preference Shares; (iii)approve raising of funds through issuance of NCDs on private placement basis;& (iv)approve raising of funds by issue of Equity Shares, GDRs, ADRs, FCCBs, fully convertible debentures, partly convertible debentures, preference shares convertible into EquityShares, &/or any other financial instruments convertible into equityShares (including warrants, or otherwise, in registered or bearer form) &/or any security convertible into EquityShares, combination of any of the aforementioned securities by way of one or more public &/or private offerings, Qualified Institutions Placement &/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law.
12-Jan-201724-Jan-2017 Quarterly Results
01-Nov-201610-Nov-2016 Quarterly Results & Interim Dividend & Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 10, 2016, inter alia, to consider & approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2016 (Q2); issuance of Masala Bonds and declaration of interim dividend, if any.
29-Jul-201613-Aug-2016 Quarterly Results
22-Apr-201606-May-2016 inter-alia, consider recommendation of dividend on Preference Shares also.
22-Jan-201611-Feb-2016 Quarterly Results
28-Oct-201513-Nov-2015 Quarterly Results
29-Jul-201510-Aug-2015 Quarterly Results
14-May-201528-May-2015 A meeting of the Board of Directors of the Company will be held on May 28, 2015, inter alia, to consider the following items: 1. Approval of the Annual Audited Consolidated and Standalone Financial Statements of the Company for the year ended March 31, 2015 and Boards’ Report along with other Annexures, 2. Approval of the Audited Consolidated and Standalone financial results of the Company for the fourth quarter and year ended March 31, 2015 and 3. Recommendation of dividend on Preference Shares, if any. Further, pursuant to Company’s code for prevention of insider trading the Trading window is closed from May 14, 2015 to May 30, 2015 (both days inclusive). The Trading Window shall re-open 48 hours after the financial results are submitted to the stock exchanges. & Audited Results
23-Jan-201504-Feb-2015 Quarterly Results
21-Oct-201403-Nov-2014 Quarterly Results & Interim Dividend
09-Sep-201415-Sep-2014 A meeting of the Board of Directors of the Company will be held on September 15, 2014, inter alia, to consider and approve amalgamation of two wholly owned subsidiaries viz Wockhardt Biopharm Limited and Vinton Healthcare Limited with Wockhardt Limited.